Today’s Stock On Watch: Richmond Brothers, Inc Just Disclosed New Rockwell Medical, Inc Position

Today's Stock On Watch: Richmond Brothers, Inc Just Disclosed New Rockwell Medical, Inc Position

The New Richmond Brothers, Inc Holding in Rockwell Medical, Inc

Richmond Brothers, Inc filed with the SEC SC 13G/A form for Rockwell Medical, Inc. The form can be accessed here: 000154046216000002. As reported in Richmond Brothers, Inc’s form, the filler as of late owns 10.7% or 5,514,327 shares of the Health Care–company.

Rockwell Medical, Inc stake is a new one for the and it was filed because of activity on October 07, 2016. We feel this shows Richmond Brothers, Inc’s positive view for the stock.

Rockwell Medical, Inc Institutional Sentiment

Latest Security and Exchange filings show 98 investors own Rockwell Medical, Inc. The institutional ownership in Q3 2015 is high, at 24.90% of the outstanding shares. This is decreased by 2104571 the total institutional shares. 12830992 were the shares owned by these institutional investors. In total 22 funds opened new Rockwell Medical, Inc stakes, 37 increased stakes. There were 16 that closed positions and 27 reduced them.

Provident Investment Management Inc is an institutional investor bullish on Rockwell Medical, Inc, owning 25108 shares as of Q3 2015 for 0.04% of its portfolio. Jw Asset Management Llc owns 4200 shares or 0.01% of its portfolio. MA Cormorant Asset Management Llc have 1.36% of their stock portfolio for 1105000 shares. Further, Bolton Lp reported stake worth 0.11% of its US stock portfolio. The MN Perkins Capital Management Inc owns 488050 shares. Rockwell Medical, Inc is 4.19% of the manager’s US portfolio.

Business Profile

Rockwell Medical, Inc. (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its lead branded drug, Triferic is indicated for iron maintenance. Triferic is an iron compound that is delivered to hemodialysis patients through dialysate, replacing the iron loss that occurs during their dialysis treatment. Its generic drug, Calcitriol, is indicated for treating secondary hyperparathyroidism in dialysis patients. It manufactures, sells, delivers and distributes hemodialysis concentrates, along with a range of ancillary products.

SEC Form 13G is required when the filer owns between (5% and 20%) of a company and plans to hold it only as a passive investor. In case the filler intend to exert control and the stake’s exceeds 20%, then 13D Form must be filed. These filings can NOT be a precursor to “change of control” events such as hostile takeovers, company breakups or others.

Insitutional Activity: The institutional sentiment decreased to 0.9 in 2016 Q2. Its down 0.26, from 1.16 in 2016Q1. The ratio turned negative, as 11 funds sold all Rockwell Medical Inc shares owned while 28 reduced positions. 9 funds bought stakes while 26 increased positions. They now own 10.76 million shares or 10.05% less from 11.96 million shares in 2016Q1.

Raymond James And owns 74,250 shares or 0% of their US portfolio. Paloma Prns Mgmt Co has 16,496 shares for 0% of their US portfolio. Teacher Retirement Of Texas accumulated 6,834 shares or 0% of the stock. Kcg Hldg accumulated 0% or 14,005 shares. Citadel Lc last reported 47,594 shares in the company. Nationwide Fund Advisors last reported 32,282 shares in the company. Thompson Davis accumulated 250 shares or 0% of the stock. Blackrock Inc reported 5,241 shares or 0% of all its holdings. Reilly Fincl Limited Liability Company, a California-based fund reported 200 shares. Citigroup Inc reported 9,661 shares or 0% of all its holdings. Royal Commercial Bank Of Canada, a Ontario – Canada-based fund reported 973 shares. Northern Tru reported 553,377 shares or 0% of all its holdings. State Board Of Administration Of Florida Retirement Sys holds 26,889 shares or 0% of its portfolio. D E Shaw & Company accumulated 0% or 127,364 shares. Teachers Inc holds 0% of its portfolio in Rockwell Medical Inc (NASDAQ:RMTI) for 74,948 shares.

Insider Transactions: Since August 12, 2016, the stock had 0 insider purchases, and 2 sales for $81,968 net activity. 8,075 shares were sold by HOLT KENNETH L, worth $54,977.

Analysts await Rockwell Medical Inc (NASDAQ:RMTI) to report earnings on November, 14. They expect $-0.10 EPS, down 100.00% or $0.05 from last year’s $-0.05 per share. After $-0.11 actual EPS reported by Rockwell Medical Inc for the previous quarter, Wall Street now forecasts -9.09% EPS growth.

The stock decreased 4.69% or $0.32 during the last trading session, hitting $6.51. Rockwell Medical Inc (NASDAQ:RMTI) has risen 3.50% since March 9, 2016 and is uptrending. It has underperformed by 3.92% the S&P500.

Rockwell Medical, Inc. is a biopharmaceutical firm targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with services and products for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The company has a market cap of $343.49 million. The Firm operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. It currently has negative earnings. The Company’s lead branded drug, Triferic is indicated for iron maintenance.

More notable recent Rockwell Medical Inc (NASDAQ:RMTI) news were published by: Fool.com which released: “3 Ways Rockwell Medical Inc. Could Turn Things Around” on October 07, 2016, also Fool.com with their article: “3 Predictions for Rockwell Medical Inc. in 2016” published on December 10, 2015, Fool.com published: “Will Rockwell Medical Inc. Sink or Swim?” on April 06, 2016. More interesting news about Rockwell Medical Inc (NASDAQ:RMTI) were released by: Fool.com and their article: “Rockwell Medical Stock Upgraded: What You Need to Know” published on August 19, 2016 as well as Fool.com‘s news article titled: “Why Rockwell Medical, Inc. Shares Are Crashing Today” with publication date: March 01, 2016.

According to Zacks Investment Research, “Rockwell Medical Technologies, Inc. manufactures hemodialysis concentrates and dialysis kits, and sells, distributes and delivers such concentrates and dialysis kits, as well as other ancillary hemodialysis products, to hemodialysis providers in the United States. Hemodialysis is a process which is able to duplicate kidney function in patients whose kidneys have failed to function properly.”

RMTI Company Profile

Rockwell Medical, Inc. (Rockwell), incorporated on October 25, 1996, is a biopharmaceutical firm targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with services and products for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Firm operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. The Company’s lead branded drug, Triferic is indicated for iron maintenance.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags:

Related posts

Leave a Comment